“Blinded clinical impressions showed almost two-third of the participants had behavioral improvements with CBD,” researchers reported.
The post Clinical Trial: FDA-Approved CBD Formulation Associated With Clinically Evident Improvements in Autistic Boys appeared first on NORML.
“Regular 3-month application of the emulsion based on cannabis sativa L. oil considerably reduced inflammation, erythema, pruritus, and scaling of the skin,” investigators concluded.
The post Case Report: Topical Application of Hemp Seed Oil Mitigates Eczema Symptoms appeared first on NORML.
The company will host a grand opening on June 28 at the new retail facility in Broward County.
The Canadian cannabis company expanded its eligibility of the program to those with an annual income of up to 60,000 CAD.
The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.
The U.S. House voted to attach Rep. Brian Mast’s amendment—to allow Veterans Affairs to prescribe medical cannabis—to a military funding bill.
Cannabis sativa L.’s natural ability to absorb environmental toxins makes it uniquely vulnerable to ‘forever chemicals’ contamination—putting producers and retailers at serious legal risk as federal scrutiny ramps up.
The company’s new bodega-style shopping experience offers customers the freedom to browse and select their favorite items directly from shelves.
The California-born brand known for industry-leading innovation and premium products enters its 15th U.S. market.
The Canadian-based company’s proprietary genetics will be the highest potency medical cannabis products available on the Polish market.